Keywords: astrazeneca, raises, full-year, earnings, guidance, anglo-swedish, drugmaker
AstraZeneca raises full-year earnings guidance
Article | 28 July 2003
Anglo-Swedish drugmaker AstraZeneca says that it is raising its full-year 2003 earnings guidance to $1.65-$1.75 from the $1.50-$1.65 initially forecast, after ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
